psychiatryRounds

Connecting Psychiatry - Expert community for all mental health professionals

November 2003 News and Blog Posts (1)

Amersham targets Alzheimer's disease

(PSYCHIATRIC TIMES) - British pharmaceutical and life sciences company Amersham has obtained an exclusive license from the University of Pittsburgh to a class of molecules that target amyloid plaque in the brain, the cause of Alzheimer's disease. Amersham will attempt to develop PET agents for diagnosing and monitoring the progress of the disease.



For full article, please visit:…

Continue

Added by psychiatryRounds Psychiatry News on November 26, 2003 at 2:30am — No Comments

Monthly Archives

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

1999


psychiatryRounds Social Media

Sponsors

CMEinfo: Board Reviews in Anesthesia, Cardiology, Internal Medicine, Radiology

© 2019   Created by PsychiatryRounds Team.   Powered by

Badges  |  Report an Issue  |  Terms of Service